Did you know that there’s a wealth of information available on the Canadian Blood Services’ Professional Education website to help transfusion medicine health-care professionals as they navigate the COVID-19 pandemic?
Call for applications! Research funding to optimize blood product use and to train next-generation researchers
The 2020 competitions for two of the Centre for Innovation’s most important and impactful research and training funding programs are now open. The Blood Efficiency Accelerator Program supports projects that improve the use of blood products. The Postdoctoral Fellowship Program offers salary support for young investigators undertaking full-time research training in a Canadian research laboratory affiliated with Canadian Blood Services.
Two recent studies from the laboratory of Canadian Blood Services senior scientist Dr. Ed Pryzdial shed light on how viruses interact with the blood coagulation system. These interactions may give viruses an advantage in their ability to infect, but they also provide new avenues to explore in the quest to find effective antivirals.
The Ortho Award is presented each year at the Canadian Society for Transfusion Medicine annual meeting to honour an individual member who has provided a major service or innovation in transfusion medicine. Congratulations to Canadian Blood Services scientist Dr. Alan Lazarus who is the 2020 recipient.
Congratulations to the recipients of funding recently awarded through the Centre for Innovation’s Blood Efficiency Accelerator Program (or BEAP). This funding supports innovators conducting research to improve the efficient and appropriate utilization of blood and blood products while maintaining the safety of the blood system.
World Hemophilia Day, an international awareness day for hemophilia and other bleeding disorders, is held annually on April 17. Hemophilia, an inherited blood disorder that affects mostly men, impairs a person’s ability to clot blood. A study led by a researcher from the McMaster Centre for Transfusion Research suggests more men have hemophilia worldwide than previously thought, highlights the need for improved hemophilia care, and helps predict demand for the plasma protein products used to treat patients.
“There’s nothing I wouldn’t have done, knowing full well it was something only we could do. At the end of the day, Canadian Blood Services got this done. A child has been treated because we were adamant we were going to provide a solution."
For patients who have cardiac surgery, the risk of severe blood loss is high if they have a condition called acquired hypofibrinogenemia — this means they have an undersupply of an essential blood clotting protein called fibrinogen. Doctors aim to minimize their bleeding with a fibrinogen replacement product, either cryoprecipitate or fibrinogen concentrate, to restore clotting factors to normal levels. A recent study that compared both products could have an impact on how cardiac patients are treated in Canada.
Do you know of an individual whose contributions might be worthy of the Canadian Blood Services Lifetime Achievement Award? To receive this honour, a nominee’s landmark contributions must be recognized as both extraordinary and world class in the field of transfusion or transplantation medicine, stem cell or cord blood research in Canada and/or abroad. Nominations are open until May 19, 2020.
The 2020 competition for one of the Centre for Innovation’s most exciting and impactful research funding programs is now open. The Intramural Research Grant Program is a long-standing program that supports research to improve the safety and efficacy of blood products and the blood system in general.